14 May 2024
Targeting inflammation in AMI: a debate
Sponsored by Novo Nordisk
Anchorperson:
R. Mehran
Discussants:
D. Capodanno, W. Jukema
Summary
Watch this session to explore inflammation's role in AMI, from atherosclerosis to post-infarct remodeling. Find out more about IL-6's significance in future MACE risk and cardiac status deterioration post-AMI, and delve into targeting inflammation via IL-6, evaluating short and long-term impacts.
Learning Objectives
- To highlight the role of inflammation in AMI, from atherosclerosis through to post-infarct remodeling
- To discuss IL-6 as a key component in the risk of future MACE or worsening of cardiac status in patients with AMI
- To explore the impact and validity of targeting inflammation via IL-6 both in the short and long term
/slide001.jpg)
/slide002.jpg)
/slide003.jpg)
/slide004.jpg)
/slide005.jpg)
/slide006.jpg)
/slide007.jpg)
/slide008.jpg)
/slide009.jpg)
/slide010.jpg)
/slide011.jpg)
/slide012.jpg)
/slide013.jpg)
/slide014.jpg)
/slide015.jpg)
/slide016.jpg)
/slide017.jpg)
/slide018.jpg)
/slide019.jpg)
/slide020.jpg)
/slide021.jpg)
/slide022.jpg)
/slide023.jpg)
/slide024.jpg)
/slide025.jpg)
/slide026.jpg)
/slide028.jpg)
/slide029.jpg)
/slide030.jpg)
/slide031.jpg)
/slide032.jpg)
/slide033.jpg)
/slide034.jpg)
/slide035.jpg)
/slide036.jpg)
/slide037.jpg)
/slide038.jpg)
/slide039.jpg)
/slide040.jpg)
/slide041.jpg)
/slide042.jpg)
/slide043.jpg)
/slide044.jpg)
/slide045.jpg)
/slide046.jpg)
/slide047.jpg)
/slide048.jpg)
/slide049.jpg)
/slide050.jpg)
/slide051.jpg)
/slide052.jpg)
/slide053.jpg)
/slide054.jpg)
/slide055.jpg)
/slide056.jpg)
/slide057.jpg)
/slide058.jpg)
/slide059.jpg)
/slide060.jpg)
/slide061.jpg)
/slide062.jpg)
/slide063.jpg)